|
Celebrex (celecoxib) is used for relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older.
Juvenile Rheumatoid Arthritis is an autoimmune disease that affects approximately 30,000 to 60,000 children in the United States. The disease is associated with joint swelling, pain, decreased range of motion and abnormalities of growth and development. In some cases, systemic complications may occur including uveitis, a chronic inflammation of the eye. In severe, uncontrolled cases, permanent disability may occur due to progressive joint damage.
Juvenile Rheumatoid Arthritis is often a devastating disease. While there are other medicines approved for the treatment of this disorder, for some children they may have limited effectiveness or cause intolerable side effects. Celebrex will be a needed additional treatment option for children.
A 24-week study of Celebrex involving 242 patients between the ages of two and 17 years demonstrated its effectiveness in treating Juvenile Rheumatoid Arthritis.
|
